Kevin Maier

Suggest Changes
Learn More
BACKGROUND Systemic adiponectin is reduced in patients with cardiovascular disease (CVD) and low adiponectin may contribute to the pathogenesis of atherosclerosis. However, circulating adiponectin is(More)
  • 1